Regis Healthcare Limited (ASX:REG)
4.350
-0.040 (-0.91%)
Oct 14, 2026, 4:10 PM AEST
Regis Healthcare Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Regis Healthcare stock has a consensus rating of "Buy" and an average price target of $6.08. The average 1-year stock price forecast is 39.77% higher than the current stock price, while the lowest is $5.00 (+14.94%) and the highest is $7.40 (+70.11%).
Price Target: $6.08 (+39.77%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Regis Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 1 | 2 | 1 | 1 | 1 | 0 |
| Hold | 2 | 1 | 2 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $5.00 | Hold | Maintains | $5.00 | +14.94% | Sep 15, 2026 |
Unknown Analyst Macquarie No rating | Macquarie | Buy Maintains $7.40 → $5.90 | Buy | Maintains | $7.40 → $5.90 | +35.63% | Sep 3, 2026 |
| Ord Minnett | Ord Minnett | Hold Downgrades $8.40 → $6.00 | Hold | Downgrades | $8.40 → $6.00 | +37.93% | Sep 3, 2026 |
| UBS | UBS | Hold Maintains $6.75 → $5.95 | Hold | Maintains | $6.75 → $5.95 | +36.78% | Sep 3, 2026 |
| Jarden | Jarden | Hold Maintains $7.50 → $6.20 | Hold | Maintains | $7.50 → $6.20 | +42.53% | Sep 3, 2026 |
Financial Forecast
Revenue This Year
1.45B
from 1.35B
Increased by 7.55%
Revenue Next Year
1.54B
from 1.45B
Increased by 5.84%
EPS This Year
0.19
from 0.18
Increased by 3.92%
EPS Next Year
0.23
from 0.19
Increased by 18.47%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.